Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antitubercular inhaled therapy: opportunities, progress and challenges.

Rajesh Pandey1, G K Khuller

  • 1Department of Biochemistry, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India.

The Journal of Antimicrobial Chemotherapy
|March 12, 2005
PubMed
Summary

Inhaled therapies offer direct lung delivery for tuberculosis treatment, reducing side effects. Nanoparticles show promise as drug carriers, but challenges remain for clinical application.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transcriptional landscapes of dengue patients reveal associations between HERV activity and disease severity.

NAR molecular medicine·2026
Same author

Intracellular microbial shifts during COVID-19 infection and longitudinal recovery revealed by single-cell RNA sequencing.

iScience·2026
Same author

Comparative GWAS using global and Indian Reference Panels reveals non-coding drivers of COVID-19 severity and mortality.

PLoS neglected tropical diseases·2026
Same author

Remdesivir-bisPropionate, a better derivative of remdesivir against SARS-CoV-2: Comparison of in vitro and in vivo PK/PD Study as well as its therapeutic potential.

PloS one·2026
Same author

Phloretin-induced modulation in gut microbiome, mitigates colonic inflammation and alleviates colitis-associated colorectal cancer in mice.

Computational and structural biotechnology journal·2026
Same author

Functional dynamics between resident transcriptionally active microbes (TAMs) and host genes underlie Dengue severity.

PLoS neglected tropical diseases·2025

Area of Science:

  • Pulmonary medicine
  • Pharmacology
  • Biotechnology

Background:

  • Pulmonary tuberculosis is the most prevalent form of the disease.
  • Direct drug delivery to the lungs via inhalation is a rational therapeutic strategy.
  • Inhaled therapy offers advantages like targeted delivery, reduced systemic toxicity, and improved patient compliance.

Purpose of the Study:

  • To review the advancements in inhaled drug delivery systems for pulmonary tuberculosis.
  • To highlight the potential of nanoparticles as carriers for antitubercular drugs.
  • To discuss the challenges and future directions for inhaled antitubercular therapy.

Main Methods:

  • Review of existing research on inhalable antitubercular drug delivery systems.
  • Focus on nanoparticle-based drug delivery.

Related Experiment Videos

  • Comparison of dry powder inhalers and nebulization techniques.
  • Discussion of single versus multiple drug delivery strategies.

    • Main Results:

    • Nanoparticles are a highly effective tool for inhalable antitubercular drug delivery.
    • Both dry powder inhalers and nebulizers have been explored for this purpose.
    • Simultaneous delivery of multiple drugs can enhance therapeutic efficacy.
    • Synthetic polymers are more established, but natural polymers remain underexplored.

    Conclusions:

    • Inhaled antitubercular therapy holds significant promise for treating pulmonary tuberculosis.
    • Further research and development are needed to address challenges like formulation stability, large-scale production, cost, and patient education.
    • Transitioning inhaled therapy from theory to clinical practice requires overcoming these key issues.